DiNAQOR is a genetic medicine platform company pioneering early-stage drug development and manufacturing. Our patent-protected, industry leading platform is designed to overcome the challenges and limitations of advanced gene therapy development. Our platform includes an organ-specific drug delivery system; proprietary engineered heart tissue drug development technology; organ-specific AAV capsid development capabilities; and a fully integrated AAV viral vector manufacturing platform.